We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

753 hedge funds and large institutions have $55.9B invested in Allergan plc in 2014 Q3 according to their latest regulatory filings, with 138 funds opening new positions, 374 increasing their positions, 189 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more first-time investments, than exits

New positions opened: 138 | Existing positions closed: 49

98% more repeat investments, than reductions

Existing positions increased: 374 | Existing positions reduced: 189

96% more call options, than puts

Call options by funds: $1.97B | Put options by funds: $1B

41% more capital invested

Capital invested by funds: $39.7B → $55.9B (+$16.3B)

35% more funds holding in top 10

Funds holding in top 10: 84113 (+29)

12% more funds holding

Funds holding: 674753 (+79)

Holders
753
Holders Change
+79
Holders Change %
+11.72%
% of All Funds
21.84%
Holding in Top 10
113
Holding in Top 10 Change
+29
Holding in Top 10 Change %
+34.52%
% of All Funds
3.28%
New
138
Increased
374
Reduced
189
Closed
49
Calls
$1.97B
Puts
$1B
Net Calls
+$965M
Net Calls Change
+$483M
Name Holding Trade Value Shares
Change
Change in
Stake
Federated Hermes
151
Federated Hermes
Pennsylvania
$43.5M +$579K +2,586 +1%
LCM
152
Laurion Capital Management
New York
$43.2M +$40.1M +179,100 New
Korea Investment Corp
153
Korea Investment Corp
South Korea
$42.7M +$8.73M +39,000 +28%
PI
154
PGGM Investments
Netherlands
$42.6M +$39.5M +176,683 New
Fiera Capital (Canada)
155
Fiera Capital (Canada)
Quebec, Canada
$42.5M +$2.55M +11,395 +7%
TRSOTSOK
156
Teachers Retirement System of the State of Kentucky
Kentucky
$42M +$10.5M +47,071 +37%
PCMF
157
Private Capital Management (Florida)
Florida
$40.4M -$1.08M -4,816 -3%
SI
158
Standard Investments
New York
$40.3M -$19.7M -88,077 -35%
Axa
159
Axa
France
$40.3M +$16.9M +75,482 +82%
RG
160
Redmile Group
California
$39.5M -$2.86M -12,800 -7%
Macquarie Group
161
Macquarie Group
Australia
$39.4M +$18.5M +82,560 +102%
TS
162
Twin Securities
New York
$38.8M +$36M +160,935 New
Public Employees Retirement Association of Colorado
163
Public Employees Retirement Association of Colorado
Colorado
$38.8M +$4.62M +20,624 +15%
Retirement Systems of Alabama
164
Retirement Systems of Alabama
Alabama
$38.4M +$12.4M +55,357 +53%
D.E. Shaw & Co
165
D.E. Shaw & Co
New York
$37.4M -$27.8M -124,240 -44%
N
166
Nuveen
North Carolina
$37.1M -$635K -2,836 -2%
AC
167
Ascend Capital
California
$36.8M -$7.81M -34,883 -19%
HM
168
HealthCor Management
New York
$36.2M -$78.3M -350,000 -70%
RJA
169
Raymond James & Associates
Florida
$36.2M +$23.1M +103,434 +223%
SFM
170
Soros Fund Management
New York
$36.2M +$19.3M +86,054 +135%
ACM
171
Argent Capital Management
Missouri
$35.6M +$33M +147,406 New
RHBC
172
R.H. Bluestein & Co
Michigan
$35M +$13.7M +61,146 +73%
ACI
173
AMP Capital Investors
Australia
$34.6M +$9.39M +41,963 +42%
BCIM
174
British Columbia Investment Management
British Columbia, Canada
$34.4M +$6.37M +28,457 +25%
EA
175
Euclid Advisors
Connecticut
$34.3M +$2.14M +9,570 +7%

AGN Hedge Fund Activity: Q3 2014 in Review

753 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2014, worth a combined $55.9B — up 41% from $39.7B a quarter earlier.

Buyers outnumbered sellers: 138 funds opened new AGN positions and 49 closed out — a net gain of 89 holders — while 374 added to existing stakes and 189 trimmed.

The largest buyer was ClearBridge Investments, opening a new position worth an estimated $1.74B. The largest seller was AllianceBernstein, cutting an estimated $200M.

  • 753 institutional investors held Allergan plc (AGN) as of Q3 2014, up from 674 in Q2 2014.
  • Funds reported $55.9B of Allergan plc stock for Q3 2014, up 41% quarter-over-quarter.
  • 138 funds opened new Allergan plc positions in Q3 2014 and 49 closed out, a net change of +89 holders.
  • The largest Allergan plc buyer in Q3 2014 was ClearBridge Investments, an estimated $1.74B added.
  • The largest Allergan plc seller in Q3 2014 was AllianceBernstein, an estimated $200M sold.

Based on aggregated 13F filings for Q3 2014.